Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
Clinical trial NCT05136976 · RECRUITING
Trial details
- NCT number
- NCT05136976
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2027-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.